Consultant Neonatologist and Honorary Senior Clinical Lecture in Paediatrics

Oxford University Hospitals NHS Foundation Trust 

Kevin Ives trained in Cambridge, London and Brighton. He has been a Consultant Neonatologist in Oxford since 1991, with the exception of a sabbatical at Monash Medical Centre, Melbourne in 1992. An Action Research Fellowship funded his MD Thesis from Cambridge University on ‘Bilirubin transport and toxicity in the central nervous system.’ He has been the chapter author on ‘Neonatal Jaundice’ in the last three editions of The Textbook of Neonatology (Rennie and Roberton). Kevin contributed to the 2010 NICE Guideline on Neonatal Jaundice, which has provided more conformity on detection and treatment of hyperbilirubinaemia with the aim of reducing the incidence of cases of kernicterus in the UK.

Kevin was a member of the team that placed the first baby in the UK on nasal High Flow Therapy (nHFT) in November 2004. He has been an outspoken evangelist for this form of non-invasive respiratory support ever since; receiving invitations from Europe and the USA to share his experience, enthusiasm and prejudices. He was a contributing author of an ‘International Consensus Document on the use of nHFT in Neonatology’ 2017, and in recent years he has collaborated with Dr Peter Reynolds in a randomised crossover study of automated oxygen control for preterm infants receiving nasal High Flow, 2018 (https://www.ncbi.nlm.nih.gov/pubmed/30464005). He is now involved, along with several other UK centres, in evaluating the next generation of the automated oxygen module.

Kevin has 34 peer reviewed publications and is the author of 7 book chapters, including ‘Medical Malpractice in Neonatology’ for the Encyclopaedia of Forensic and Legal Medicine. Elsevier Academic Press, 2015. He has been attending and contributing to the Reason meeting for longer than he can remember and is looking forward to the challenge of Virtual Reason 2020.